Prostate Cancer

ayDCE software, mpMRI, multiparametric magnetic resonance imaging, prostate MRI, RSNA 2017, AHRA, SIIM
Technology | Magnetic Resonance Imaging (MRI) | February 13, 2017

February 13, 2017 —  aycan recently introduced ayDCE software powered by aycan workstation.

Blue Earth Diagnostics, Axumin, fluciclovine F-18, recurrent prostate cancer, Simens PETNET Solutions, increased patient access
News | Radiopharmaceuticals and Tracers | February 07, 2017

Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of radiopharmacies will...

recurrent prostate cancer, hormone therapy, radiation therapy, Cedars-Sinai study, New England Journal of Medicine
News | Prostate Cancer | February 03, 2017

Adding hormonal therapy to radiation treatment can significantly improve the average long-term survival of men with...

PET/CT, primary and metastatic prostate cancer, Journal of Nuclear Medicine study, JNM

Ga-68-BBN PET/CT of a 64-year-old man newly diagnosed with prostate cancer by biopsy. Multiple bone metastasis lesions (arrows) were detected. Image courtesy of Jingjing Zhang, Peking Union Medical College, Beijing, China.

News | Prostate Cancer | February 02, 2017

In the featured article from the February 2017 issue of the Journal of Nuclear Medicine, researchers document the...

prostate cancer, PI-RADS, best clinical research paper, European Urology
News | Prostate Cancer | January 18, 2017

An article promoting standardized imaging efforts to improve diagnosis and treatment of prostate cancer has been...

News | Radiopharmaceuticals and Tracers | January 06, 2017

New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of prostate cancer...

MRI-guided focused ultrasound
News | Focused Ultrasound Therapy | December 22, 2016

Insightec Ltd. announced that the Exablate Prostate system received CE Mark for treating locally-confined prostate...

prostate, CT scan
News | Prostate Cancer | December 22, 2016

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics...

News | Prostate Cancer | December 14, 2016

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on small molecules that...

News | Prostate Cancer | December 09, 2016

Exact Imaging, a leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance...

prostate cancer, PET imaging, Johns Hopkins, Daniel Thorek, 11B6 antibody

Uptake of 89Zr-11B6 in the prostate of a transgenic mouse with prostate cancer. Image courtesy of Daniel Thorek

News | Prostate Cancer | November 30, 2016

An international group of researchers report success in mice of a method of using positron emission tomography (PET...

Augmenix, SpaceOAR System, prostate cancer, new CPT code, AMA, American Medical Association
Technology | Prostate Cancer | November 10, 2016

Augmenix Inc. announced that the American Medical Association (AMA) has granted a Category I, Current Procedural...

News | Prostate Cancer | November 02, 2016

November 2, 2016 — A new report on Swedish men with non-aggressive prostate cancer suggests a lot more American men...

Augmenix, SpaceOAR System, prostate cancer, three-year clinical data results, ASTRO 2016
News | Prostate Cancer | October 27, 2016

Augmenix Inc. announced the three-year results from the SpaceOAR System Prostate Cancer US Pivotal Clinical Trial in...

intermediate-risk prostate cancer, brachytherapy versus external beam therapy, radiation therapy, RT, ASTRO 2016
News | Brachytherapy Systems | October 25, 2016

For men with intermediate-risk prostate cancer, radiation treatment with brachytherapy alone can result in similar...

Axumin, fluciclovine F-18, PET agent, Phase 3 study, recurrent prostate cancer detection, Blue Earth Diagnostics
News | Prostate Cancer | October 25, 2016

Blue Earth Diagnostics Ltd. announced the peer-reviewed publication of results from a Phase 3 clinical trial of...

prostate cancer, SBRT, stereotactic body radiotherapy, ASTRO 2016 study, Robert Meier, control, side effects, toxicity
News | Radiation Therapy | October 06, 2016

High-dose stereotactic body radiotherapy (SBRT) for men newly diagnosed with low- or intermediate-risk prostate...

prostate cancer, ProtecT trial findings, ASTRO 2016, radiation therapy
News | Radiation Therapy | October 03, 2016

The American Society for Radiation Oncology (ASTRO) extended its congratulations to the authors and investigators in...

Overlay Init